Article info
PDFLetter
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India
- Correspondence to Dr Sanjay K Bhadada, Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India; bhadadask{at}rediffmail.com
Citation
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India
Publication history
- Accepted May 30, 2021
- First published June 8, 2021.
Online issue publication
March 01, 2022
Article Versions
- Previous version (8 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage